Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Vitamin E diffused highly cross-linked polyethylene in total hip arthroplasty at five years: a randomised controlled trial using radiostereometric analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mismatch 'never events' in hip and knee arthroplasty: a cohort and intervention study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Early patient-reported outcomes versus objective function after total hip and knee arthroplasty: a prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The impact of lifestyle risk factors on the rate of infection after surgery for a fracture of the ankle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mismatch 'never events' in hip and knee arthroplasty: a cohort and intervention study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Incidence of surgical interventions for metastatic bone disease in the extremities: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

AIMS: The objective of this five-year prospective, blinded, randomised controlled trial (RCT) was to compare femoral head penetration into a vitamin E diffused highly cross-linked polyethylene (HXLPE) liner with penetration into a medium cross-linked polyethylene control liner using radiostereometric analysis.

PATIENTS AND METHODS: Patients scheduled for total hip arthroplasty (THA) were randomised to receive either the study E1 (32 patients) or the control ArComXL polyethylene (35 patients). The median age (range) of the overall cohort was 66 years (40 to 76).

RESULTS: The five-year median (interquartile range) proximal femoral head penetration into the E1 was -0.05 mm (-0.13 to -0.02) and 0.07 mm (-0.03 to 0.16) for ArComXL. At three and five years, the penetration was significantly greater in the ArComXL group compared with the E1 group (p = 0.029 and p = 0.019, respectively). All patient-reported outcomes (PROs) improved significantly from the pre-operative interval compared with those at one year, and remained favourable at five years. There were no differences between the two groups at any interval.

CONCLUSION: The five-year results showed that E1 polyethylene does not wear more than the control, ArComXL. This is the longest-term RCT comparing the wear performance and clinical outcome of vitamin E diffused HXLPE with a previous generation of medium cross-linked polyethylene. Cite this article: Bone Joint J 2017;99-B:577-84.

OriginalsprogEngelsk
TidsskriftThe bone & joint journal
Vol/bind99-B
Sider (fra-til)577-584
ISSN2049-4394
DOI
StatusUdgivet - 28 apr. 2017

ID: 50314667